February 24, 2022
China Law & Practice named China Biologic Products’ take-private, a transaction on which Gibson Dunn advised, as its M&A Deal of the Year at the China Law & Practice Awards 2021. The awards were announced on February 24, 2022.
Gibson, Dunn & Crutcher’s Beijing office is dedicated to servicing the needs of our clients establishing operations and doing business in China and those of our Chinese clients in their international transactions. The Beijing office works closely with lawyers in our Hong Kong office, enabling us to provide Hong Kong law capability where relevant.